Wuxi AppTec CoWUXIF 81 5-Year Yield-on-Cost % is 7.77 as of Jul. 12, 2026, which is 72% above its 10-year median of 4.51. GuruFocus rates WUXIF with a GF Score™ of 81/100 and a GF Value™ of $12.32 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 65 Medical Diagnostics & Research companies, Wuxi AppTec Co ranks better than 86.15% on this metric.
Wuxi AppTec Co's yield on cost for the quarter that ended in Mar. 2026 was 7.77.
The historical rank and industry rank for Wuxi AppTec Co's 5-Year Yield-on-Cost % or its related term are showing as below:
WUXIF'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.9 Med: 4.51 Max: 18.31
Current: 7.77
During the past 12 years, Wuxi AppTec Co's highest Yield on Cost was 18.31. The lowest was 0.90. And the median was 4.51.
WUXIF's 5-Year Yield-on-Cost % is ranked better than 86.15% of 65
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.42
vs WUXIF: 7.77
Wuxi AppTec Co (OTCPK:WUXIF) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Wuxi AppTec Co 5-Year Yield-on-Cost % Related Terms
WUXIF vs TMO, DHR, IDXX: 5-Year Yield-on-Cost % Comparison
For the Diagnostics & Research subindustry, Wuxi AppTec Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wuxi AppTec Co 5-Year Yield-on-Cost % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Wuxi AppTec Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Wuxi AppTec Co's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Wuxi AppTec Co is calculated as
Wuxi AppTec Co (WUXIF) has a 5-Year Yield-on-Cost % of 7.77 as of Jul. 12, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Wuxi AppTec Co and its competitors. This is 72% above median its historical median of 4.51. Over the past decade, Wuxi AppTec Co's 5-Year Yield-on-Cost % has ranged from 0.90 to 18.31. According to the industry distribution chart, Wuxi AppTec Co ranks #9 out of 65 companies in the Medical Diagnostics & Research industry, placing it in the top 13.8%.
Is Wuxi AppTec Co's 5-Year Yield-on-Cost % too high?
Wuxi AppTec Co's current 5-Year Yield-on-Cost % of 7.77 is 72% above median its 10-year median of 4.51. Over the past 10 years, this metric has ranged from a low of 0.90 to a high of 18.31. The Medical Diagnostics & Research industry median 5-Year Yield-on-Cost % is 2.42. Wuxi AppTec Co's value of 7.77 is 221.1% above this industry median. Based on the distribution chart, Wuxi AppTec Co ranks #9 out of 65 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Wuxi AppTec Co has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Wuxi AppTec Co's 5-Year Yield-on-Cost % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Wuxi AppTec Co ranks #9 out of 65 companies for 5-Year Yield-on-Cost %. This places Wuxi AppTec Co in the top 14% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.42. Wuxi AppTec Co's value of 7.77 is 221.1% above this benchmark. Historically, Wuxi AppTec Co's own 5-Year Yield-on-Cost % has ranged from 0.90 to 18.31 over the past decade. While the company's 10-year median is 4.51 vs. the industry median of 2.42, Wuxi AppTec Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Diagnostics & Research company?
The median 5-Year Yield-on-Cost % among Medical Diagnostics & Research companies is 2.42, based on 65 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wuxi AppTec Co's current 5-Year Yield-on-Cost % of 7.77 is 221.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Wuxi AppTec Co and its competitors. For the Medical Diagnostics & Research industry, the median 5-Year Yield-on-Cost % is 2.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wuxi AppTec Co's current 5-Year Yield-on-Cost % is 7.77, which is 72% above median its own 10-year median of 4.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wuxi AppTec Co stock overvalued right now?
Based on GuruFocus' analysis, Wuxi AppTec Co (WUXIF) is currently considered Significantly Overvalued. The stock's GF Value™ is $12.32, compared to a current price of $20.58 — trading 67% above its estimated fair value. The current 5-Year Yield-on-Cost % is 7.77, which is 72% above median its 10-year median of 4.51 and 221.1% above the Medical Diagnostics & Research industry median of 2.42. Wuxi AppTec Co's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Wuxi AppTec Co (WUXIF), the current 5-Year Yield-on-Cost % is 7.77 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wuxi AppTec Co (WUXIF) Overvalued in 2026?
Based on GuruFocus' analysis, Wuxi AppTec Co stock appears to be overvalued.
The current stock price of $20.58 is trading 67% above its estimated GF Value™ of $12.32.
GuruFocus considers Wuxi AppTec Co to be Significantly Overvalued.
Key valuation signals for WUXIF:
5-Year Yield-on-Cost %: 7.77 (72% above median its 10-year median of 4.51)
GF Value™: $12.32 vs. price of $20.58 (67% above fair value)
Industry Position: 221.1% above the Medical Diagnostics & Research median (#9 of 65)
No single metric tells the full story. See the WUXIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by PRC, Europe, and other regions.
81GF Score
Get the complete analysis for WUXIF
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WUXIF has been successfully added to your 